Legal Opinion

In re Remicade Antitrust Litig.

District Court, E.D. Pennsylvania

Decided December 4, 2018No. CIVIL ACTION No. 17-cv-04326; No. 18-cv-00303PublishedCited by 13 opinions

1Opinion of the CourtJoyner, District Judge

Before the Court are Defendants' Johnson & Johnson and Janssen Biotech, Inc. (collectively "Janssen") ("J & J") Motion to Dismiss for failure to state a claim under Fed. R. Civ. P. 12(b)(6) (Doc. No. 67-1), Indirect and Direct Purchaser Plaintiffs' Joint Opposition thereto (Doc. No. 73), and Defendants' Reply in Support thereof (Doc. No. 75).

I. Background

This case arises from an antitrust action brought by Direct and Indirect Purchasers of Defendants' drug Remicade, against Johnson & Johnson, along with its wholly owned subsidiary, Janssen Biotech, Inc. (collectively, "J & J"), alleging…

2Cases cited73 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
  4. Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
  5. Lewis v. CaseySupreme Court of the United States · 1996

68 more not listed; retrieve them via the Exa API.

3Cited by13 opinions

  1. In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2019
  2. Presque IsleColon & Rectal Surgery v. Highmark HealthDistrict Court, W.D. Pennsylvania · 2019
  3. A & B Campbell Family v. Chesakpeake Energy CorporationDistrict Court, M.D. Pennsylvania · 2024
  4. A&B Campbell Family LLC, et al. v. Williams Partners, L.P., et al.District Court, M.D. Pennsylvania · 2025
  5. LIBERTY TOWERS PHILLY LP v. AMERICAN TOWER CORPORATIONDistrict Court, E.D. Pennsylvania · 2020

8 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API